Special Edition 2015: Insights into Inhaled ABX Scheduling

e-Cystic Fibrosis Review is a monthly CE series for nurses, nurse practitioners, and others involved in the care of patients with Cystic Fibrosis. It provides updates on the latest research, best practices, and issues currently under debate, as well as a concise review of relevant journal literature.

(Special Edition 2015)


Target Audience

Nurses and health care professionals involved in the care of patients with Cystic Fibrosis.

Learning Objectives

After participating in this activity, the participant will demonstrate the ability to: 

  • Review the history of the current approved regimen for inhaled antibiotics for the treatment of airways infection in patients with cystic fibrosis.
  • Identify the perceived inadequacies of inhaled antibiotics and current practice patterns in patients with cystic fibrosis.
  • Evaluate the findings of the recently completed trial investigating continuous alternating inhaled antibiotic therapy for patients with cystic fibrosis.


Additional information
Contact email: 
Course summary
Available credit: 
  • 1.00 ANCC
  • 1.00 Attendance
Registration opens: 
Registration closes: 
Patrick Flume, MD
Professor of Medicine and Pediatrics
Medical University of South Carolina
Charleston, South Carolina


Dr. Patrick Flume reports that he served as a consultant for Novartis, Vertex Pharmaceuticals, Inc, and Pharmaxis Limited. In addition he has received grant and research support from Novartis, Vertex Pharmaceuticals, Inc, Pharmaxis Limited, Boehringer Ingelheim Pharmaceuticals, Savara Pharma, and KaloBios. 

Unlabeled/Unapproved Uses

Dr. Patrick Flume reports that the activity will not contain any discussion of off-label or unapproved drugs or products. 

Available Credit

  • 1.00 ANCC
  • 1.00 Attendance


Please login or register to take this course.

Required Hardware/software

Make sure your Adobe flash is updated by clicking HERE